In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other most profitable biotech stocks to buy right now. With improved market ...

JPMorgan lowered the firm’s price target on Regeneron (REGN) to $1,000 from $1,100 and keeps an Overweight rating on the shares. The firm expects a “messy” Q1 report for Eylea but sees the ...

Spears shares daughter Maddie with her ex-fiancé Casey Aldridge Jamie Lynn Spears/Instagram Jamie Lynn Spears is reveling in her eldest daughter’s high school milestone! On Sunday, March 30 ...

In a March 31 Instagram post, the actor shared several photos of Maddie dressed to the lilac nines. Her daughter wore a beaded pastel purple gown and metallic heels, which complimented her ...

Jamie Lynn Spears is celebrating a milestone moment for daughter Maddie. Spears, 33, shared a carousel of photos via Instagram on Sunday, March 30, featuring Maddie, 16, in a floor-length lilac ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other blue chip stocks to invest in at 52-week lows. For the first time since ...

President Trump said he isn’t worried the planned tariffs on other countries could push them toward China. Photo: Francis Chung/Press Pool But if the European Union imposes a 50% retaliatory tar ...

Pete Davidson and new girlfriend Elsie Hewitt have hit Scotland for the wedding of Jane’s Addiction’s guitarist Dave Navarro to fashion designer Vanessa DuBasso. Hewitt has posted pics of the ...

Meanwhile, Maddie–whom Spears shares with ex fiancé Casey Aldridge–looked pretty in purple with a lilac-hued gown from Sherri Hill that featured a thigh-high slit, metallic beading all over ...

Jamie Lynn Spears’ 16-year-old daughter, Maddie, just reached a special milestone: her senior prom! On March 30, Spears, 33, posted several pictures of Maddie posing for photos in a beaded lilac ...

Earlier in 2019 Sanofi also paid Regeneron $462 million to exit from an immuno-oncology alliance formed in 2015, and in 2017 said they would end discovery research in new antibody drugs.

Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.